Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-2 of 2
Keywords: RAS GTPase
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
The ERK mitogen-activated protein kinase signaling network: the final frontier in RAS signal transduction
Available to Purchase
Journal:
Biochemical Society Transactions
Biochem Soc Trans (2021) 49 (1): 253–267.
Published: 05 February 2021
.... Correspondence: Channing J. Der ( [email protected] ) 13 10 2020 30 12 2020 8 1 2021 © 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2021 extracellular signal-regulated kinases mitogen-activated protein kinases PDAC RAS GTPase...
Articles
Inhibition of RAS: proven and potential vulnerabilities
Available to Purchase
Journal:
Biochemical Society Transactions
Biochem Soc Trans (2020) 48 (5): 1831–1841.
Published: 01 September 2020
... to be pharmacologically effective. allosteric inhibitor cancer chemotherapy dimerization monobody RAS GTPase RAS has been at the forefront of cancer research due to its prominence in the onset and progression of human cancers. Somatic mutations in RAS are a hallmark of many cancers with ∼19% of cancer...